We conclude that the effect of JZG on hepatic steatosis is likely to be multifactorial: JZG decreases the activation of SREBP-1c through inhibiting LXRα-mediated SREBP-1c transcription, as well as through inhibiting the maturation of SREBP-1c independent of LXRα. The gene discussed is SREBF1; the disease is fatty liver disease.